MediSpectra raises $9 million
This article was originally published in Clinica
Executive Summary
MediSpectra has raised $9 million in a private placement with venture capital firms. The company, based in Lexington, Massachusetts, will use the proceeds to fund the development of its core product, a hand-held device for the detection of cervical cancer.